97Ru-transferrin uptake in tumor and abscess.

Area of Science:

• Nuclear Medicine
• Radiopharmaceutical Chemistry
• Oncology

Background:

• Gallium-67-citrate (Ga) is a common radiopharmaceutical for tumor and abscess imaging.
• Transferrin is a plasma protein that binds to various metal ions and can be labeled with radionuclides.

Purpose of the Study:

• To evaluate the efficacy of Ruthenium-97-transferrin (Ru-TF) for tumor and abscess localization compared to other radiopharmaceuticals.
• To investigate the role of the transferrin ligand in tumor targeting.

Main Methods:

• Comparison of radiotracer uptake in tumor and abscess-bearing animals.
• Utilized 97Ru-transferrin, 67Ga-citrate, and 123I-transferrin.
• Whole body autoradiography (WBARG) and gamma camera imaging.

Main Results:

• Ru-TF demonstrated a three times higher maximal concentration in mouse tumors than 67Ga-citrate.
• Ru-TF allowed visualization of abscesses in rabbits as early as 30 minutes post-injection.
• 123I-transferrin showed similar tumor concentration to 67Ga but a low tumor-to-blood ratio.

Conclusions:

• Ru-TF shows potential advantages over 67Ga-citrate for tumor and abscess localization due to higher lesion concentration.
• Tumor targeting appears to be a property of the radionuclide-ligand complex (e.g., Ru-TF) rather than the radionuclide alone.